Hung-chang Wu
Tainan, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
PIP5K3 upregulation correlates with unfavorable prognosis in patients with nasopharyngeal carcinoma.
PIP5K3 upregulation correlates with unfavorable prognosis in patients with nasopharyngeal carcinoma.
Journal: Histology and histopathology
Published: September 30, 2025
Effusion cytology of EBV-associated lymphoma: a concise review.
Journal: Blood research
Published: April 29, 2025
Upregulated Claudin-18.2 Is a Poor Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent Chemoradiotherapy.
Journal: Oncology
Published: March 19, 2025
The clinicopathological significance and prognostic impact of 14-3-3σ/stratifin expression on patients with surgically resectable intrahepatic cholangiocarcinoma.
Journal: Asian journal of surgery
Published: May 01, 2024
Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone Lymphoma.
Journal: Diagnostics (Basel, Switzerland)
Published: February 20, 2024
Multiple myeloma masquerades as T-cell lymphoma by nodal presentation with anaplastic morphology and expression of CD3 and CD45.
Journal: Pathology
Published: February 04, 2024
LAMC2 is a potential prognostic biomarker for cholangiocarcinoma.
Journal: Oncology letters
Published: April 28, 2023
Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma.
Journal: Scientific reports
Published: February 10, 2023
Case report: Heterogenous SMARCA4-deficient thoracic non-small cell lung carcinoma with various responses to nivolumab.
Journal: Frontiers in immunology
Published: December 25, 2022
No survival benefit from adding chemotherapy to adjuvant radiation in advanced major salivary gland cancer.
Journal: Scientific reports
Published: September 12, 2022
Upregulated Ubiquitin D is a Favorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent Chemoradiotherapy.
Journal: OncoTargets and therapy
Published: June 28, 2022
Last Updated: 09/26/2026